In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: A multicenter sample

This publication has 17 references indexed in Scilit:

• The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci
  Clinical Microbiology & Infection, 1997
• Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group
  Published by American Medical Association (AMA) ,1996
• In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood
  Antimicrobial Agents and Chemotherapy, 1995
• Bacteremia due to viridans streptococci in neutropenic patients: A review
  The American Journal of Medicine, 1994
• Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States I. Study on the threat of emerging resistances: Real or perceived?
  Diagnostic Microbiology and Infectious Disease, 1994
• Emergence of drug-resistant pneumococcal infections in the United States
  JAMA, 1994
• Bacteremia Due to Viridans Streptococcus in Neutropenic Patients with Cancer: Clinical Spectrum and Risk Factors
  Clinical Infectious Diseases, 1994
• Antimicrobial Resistance in Streptococcus pneumoniae: An Overview
  Clinical Infectious Diseases, 1992
• INVASIVE GROUP A STREPTOCOCCAL INFECTIONS
  Infectious Disease Clinics of North America, 1992
• Activity of cefepime (BMY-28142) and cefpirome (HR 810) against Gram-negatire bacilli resistant to cefotaxime or ceftaxidime
  Journal of Antimicrobial Chemotherapy, 1989